The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind

Karschnia P, Tonn JC, Cahill DP (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Clinical Cancer Research American Association for Cancer Research

Book Volume: 30

Pages Range: 4811-4812

Journal Issue: 21

DOI: 10.1158/1078-0432.CCR-24-1819

Abstract

Supramaximal resection beyond the contrast-enhancing tumor borders represents an emerging surgical strategy for patients with newly diagnosed glioblastoma. A recent study provides evidence detailing the interactive effects of more aggressive surgery on other clinical predictors of outcome, supporting guidance for surgical decision-making and informing clinical trialists about the need to stratify for extent of resection.

Authors with CRIS profile

Philipp Karschnia Department of Neurosurgery

Involved external institutions

Klinikum der Universität München DE Germany (DE) Veterans Affairs Healthcare System Boston and Harvard Medical School US United States (USA) (US)

How to cite

APA:

Karschnia, P., Tonn, J.C., & Cahill, D.P. (2024). The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind. Clinical Cancer Research, 30(21), 4811-4812. https://doi.org/10.1158/1078-0432.CCR-24-1819

MLA:

Karschnia, Philipp, Joerg Christian Tonn, and Daniel P. Cahill. "The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind." Clinical Cancer Research 30.21 (2024): 4811-4812.

BibTeX: Download